Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence George PentheroudakisGeorge LazaridisNicholas Pavlidis Review 22 September 2009 Pages: 1 - 11
Prognosis of BRCA-associated breast cancer: a summary of evidence L. BordeleauS. PanchalP. Goodwin Review 30 September 2009 Pages: 13 - 24
Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer Sumanta K. PalBarrett H. ChildsMark Pegram Review 01 October 2009 Pages: 25 - 32
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment T. Ramón y CajalA. AltésM. Baiget Preclinical Study 03 February 2009 Pages: 33 - 38
Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth Jieying ZhaoGuangchun ChenJian Lu Preclinical Study 04 February 2009 Pages: 39 - 51
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients Shuzhen LiuStephen K. ChiaTorsten O. Nielsen Preclinical study 10 February 2009 Pages: 53 - 61
Regulation of αB-crystallin gene expression by the transcription factor Ets1 in breast cancer Joshua D. BosmanFruma YehielyVincent L. Cryns Preclinical study 11 February 2009 Pages: 63 - 70
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305 Cinzia GiordanoYukun CuiSuzanne A. W. Fuqua Preclinical Study 11 February 2009 Pages: 71 - 85
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers Sarai Palanca SuelaEva Esteban CardeñosaOn Behalf of the Group for Assessment of Hereditary Cancer of Valencia Community Preclinical study 12 February 2009 Pages: 87 - 93
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) Aristides PolyzosNikolaos MalamosDimitris Mavroudis Clinical trial 28 July 2009 Pages: 95 - 104
Pain perception and detailed visual pain mapping in breast cancer survivors Sebastian M. JudPeter A. FaschingMayada R. Bani Clinical trial 30 July 2009 Pages: 105 - 110
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer Qamar J. KhanPavan S. ReddyCarol J. Fabian Clinical trial 05 August 2009 Pages: 111 - 118
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response Jorma J. de RondeJuliane HannemannSjoerd Rodenhuis Clinical trial 08 August 2009 Pages: 119 - 126
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group Kenichi InoueKazuhiko NakagamiShinzaburo Noguchi Clinical trial 19 August 2009 Pages: 127 - 136
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer Elisabeth R. GarwoodAnjali S. KumarLaura J. Esserman Clinical trial 29 August 2009 Pages: 137 - 144
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial Evandro de AzambujaWorta McCaskill-StevensMartine Piccart-Gebhart Clinical trial 03 September 2009 Pages: 145 - 153
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer O. C. FreedmanE. AmirM. Clemons Clinical trial 04 September 2009 Pages: 155 - 161
Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma? Hye In LimJae Hyuck ChoiSeok Jin Nam Clinical trial 17 September 2009 Pages: 163 - 167
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG) Antoaneta TomovaRupert BartschChristoph C. Zielinski Clinical trial 19 September 2009 Pages: 169 - 176
Breast cancer-related preferences among women with and without BRCA mutations Victor R. GrannPriya PatelDawn Hershman Epidemiology 26 March 2009 Pages: 177 - 184
Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database Louise A. BrintonJ. Daniel CarreonGloria Gridley Epidemiology 29 March 2009 Pages: 185 - 192
Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer Wonshik HanSo Young KangThe Korean Breast Cancer Society Epidemiology 07 April 2009 Pages: 193 - 200
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms Anna JakubowskaJacek GronwaldUte Hamann Epidemiology 10 April 2009 Pages: 201 - 211
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis Mahasin S. MujahidNancy K. JanzSteven J. Katz Epidemiology 10 April 2009 Pages: 213 - 220
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers Roger L. MilneAna OsorioJavier BenÃtez Epidemiology 16 April 2009 Pages: 221 - 232
Identification of a novel mutations BRCA1*c.80 + 3del4 and BRCA2*c.6589delA in Slovak HBOC families Michal KonecnyMiriam VizvaryovaEva Weismanova Brief Report 15 November 2008 Pages: 233 - 237
Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1 Christopher A. PettigrewJuliet D. FrenchMelissa A. Brown Brief Report 09 December 2008 Pages: 239 - 247
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines Sivasundaram KarnanMorassa MohseniHiroyuki Konishi Letter to the Editor 08 July 2009 Pages: 249 - 251
Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials Athanassios Kyrgidis Letter to the Editor 08 July 2009 Pages: 253 - 254
